Media Summary: Brandon Farris, Executive VP of the Steel Manufacturers Association, discusses the new 'Steel Strong' campaign and highlights ... The public discussion has focused largely on where SARS-CoV-2 came from. But perhaps the more important question is what ... A message from our President and CEO Mary-Ann Etiebet, M.D..

Vital Difference Exec Touts Impact - Detailed Analysis & Overview

Brandon Farris, Executive VP of the Steel Manufacturers Association, discusses the new 'Steel Strong' campaign and highlights ... The public discussion has focused largely on where SARS-CoV-2 came from. But perhaps the more important question is what ... A message from our President and CEO Mary-Ann Etiebet, M.D.. Don Lloyd-Jones, MD, ScM, vice chair of the program committee for Scientific Sessions 2018, comments on the results of the ... On 1 July 2026, CPE hosted the webinar "EU Biotech Act & Clinical Trials: How can the Act accelerate early access for patients? Terence Friedlander, MD, University of California, San Francisco, CA, highlights key factors physicians must consider when ...

We create the pathway to activate & balance the 7 Pillars of Health & give you the tools to attain Medical research results are not always what they seem. Diabetes physician, Victor Montori, MD, discusses tangible examples of ... Christopher Kwolek (Boston, USA) talks to VEITHtv about the “truly revolutionary” LEOPARD trial which evaluated the AFX EVAR ... As an implementation scientist at University of Utah Health, Chelsey Schlechter, PhD, works to translate research best ... A webinar at the Nutrition for Growth Summit 2025 about the benefits of integrating childhood vaccination and nutrition services, ...

Photo Gallery

'VITAL DIFFERENCE': Exec touts impact of Section 232 tariffs on steel industry
The Gain-of-Function Debate Is About More Than COVID Origins
Every Role is Vital: Meet Danica Xiao, VP of AI
Performance+ Introduction
Vital Strategies 2024 Impact Report
VITAL Commentary
EU Biotech Act & Clinical Trials: How can the Act accelerate early access for patients? - Webinar
Efficacy and toxicity considerations when selecting patients for ADCs
Do something DIFFERENT, obtain DIFFERENT RESULTS!
Victor Montori, MD: Direct effects of Comparative Effectiveness Research
LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts
Vitae 2026--Chelsey Schlechter: From Evidence to Impact
View Detailed Profile
'VITAL DIFFERENCE': Exec touts impact of Section 232 tariffs on steel industry

'VITAL DIFFERENCE': Exec touts impact of Section 232 tariffs on steel industry

Brandon Farris, Executive VP of the Steel Manufacturers Association, discusses the new 'Steel Strong' campaign and highlights ...

The Gain-of-Function Debate Is About More Than COVID Origins

The Gain-of-Function Debate Is About More Than COVID Origins

The public discussion has focused largely on where SARS-CoV-2 came from. But perhaps the more important question is what ...

Every Role is Vital: Meet Danica Xiao, VP of AI

Every Role is Vital: Meet Danica Xiao, VP of AI

At GE HealthCare, every role is

Performance+ Introduction

Performance+ Introduction

Performance+ Introduction

Vital Strategies 2024 Impact Report

Vital Strategies 2024 Impact Report

A message from our President and CEO Mary-Ann Etiebet, M.D..

VITAL Commentary

VITAL Commentary

Don Lloyd-Jones, MD, ScM, vice chair of the program committee for Scientific Sessions 2018, comments on the results of the ...

EU Biotech Act & Clinical Trials: How can the Act accelerate early access for patients? - Webinar

EU Biotech Act & Clinical Trials: How can the Act accelerate early access for patients? - Webinar

On 1 July 2026, CPE hosted the webinar "EU Biotech Act & Clinical Trials: How can the Act accelerate early access for patients?

Efficacy and toxicity considerations when selecting patients for ADCs

Efficacy and toxicity considerations when selecting patients for ADCs

Terence Friedlander, MD, University of California, San Francisco, CA, highlights key factors physicians must consider when ...

Do something DIFFERENT, obtain DIFFERENT RESULTS!

Do something DIFFERENT, obtain DIFFERENT RESULTS!

We create the pathway to activate & balance the 7 Pillars of Health & give you the tools to attain

Victor Montori, MD: Direct effects of Comparative Effectiveness Research

Victor Montori, MD: Direct effects of Comparative Effectiveness Research

Medical research results are not always what they seem. Diabetes physician, Victor Montori, MD, discusses tangible examples of ...

LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts

LEOPARD trial three-year data provide head-to-head comparison of AFX2 with other endografts

Christopher Kwolek (Boston, USA) talks to VEITHtv about the “truly revolutionary” LEOPARD trial which evaluated the AFX EVAR ...

Vitae 2026--Chelsey Schlechter: From Evidence to Impact

Vitae 2026--Chelsey Schlechter: From Evidence to Impact

As an implementation scientist at University of Utah Health, Chelsey Schlechter, PhD, works to translate research best ...

Vital Connections: Immunisation-Nutrition Service Linkages for Synergy, Scale and Impact

Vital Connections: Immunisation-Nutrition Service Linkages for Synergy, Scale and Impact

A webinar at the Nutrition for Growth Summit 2025 about the benefits of integrating childhood vaccination and nutrition services, ...